Literature DB >> 12355448

IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis.

Lars Svensson1, Kutty Selva Nandakumar, Asa Johansson, Liselotte Jansson, Rikard Holmdahl.   

Abstract

Rheumatoid arthritis as well as collagen-induced arthritis (CIA) is thought to involve T cell autoimmunity of the Th1 type and the Th2 cytokine IL-4 has been proposed to play a suppressive role. To exclude a possible skewing role of the mycobacteria used in the complete Freund's adjuvant (CFA) we induced CIA with type II collagen (CII) in incomplete Freund's adjuvant (IFA). Our results show that IL-4 deficiency leads to a lesser susceptibility to arthritis and lower B and T cell responses if induced with CII/IFA but not if induced with CII/CFA. In addition, IL-4-deficient mice were less susceptible to arthritis induced with monoclonal anti-CII antibodies. However, mice immunized with CII/IFA later developed a chronic relapsing disease, which was promoted by IL-4 deficiency. We conclude that IL-4 plays different roles depending on the type of adjuvant used and the phase (acute or chronic) of the clinical disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12355448     DOI: 10.1002/1521-4141(2002010)32:10<2944::AID-IMMU2944>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  Cytokine-based immunointervention in the treatment of autoimmune diseases.

Authors:  L Adorini
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

2.  TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis.

Authors:  Y Ohnishi; A Tsutsumi; D Goto; S Itoh; I Matsumoto; M Taniguchi; T Sumida
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

3.  STAT6 and IL-10 are required for the anti-arthritic effects of Schistosoma mansoni via different mechanisms.

Authors:  Y Osada; Y Horie; S Nakae; K Sudo; T Kanazawa
Journal:  Clin Exp Immunol       Date:  2018-10-15       Impact factor: 4.330

4.  Adjuvant properties of a biocompatible thermo-responsive polymer of N-isopropylacrylamide in autoimmunity and arthritis.

Authors:  Akhilesh Kumar Shakya; Ashok Kumar; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2011-05-04       Impact factor: 4.118

Review 5.  FcgammaRII and multi-system autoimmune disease.

Authors:  Nicholas C van de Velde; Patricia L Mottram; P Mark Hogarth
Journal:  Springer Semin Immunopathol       Date:  2006-11-08

Review 6.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review.

Authors:  Dolores B Njoku
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

7.  Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.

Authors:  Malin Hultqvist; Peter Olofsson; Jens Holmberg; B Thomas Bäckström; Jesper Tordsson; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

8.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.

Authors:  Dolores B Njoku; Zhaoxia Li; Nicole D Washington; Jenelle L Mellerson; Monica V Talor; Rajni Sharma; Noel R Rose
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

9.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes.

Authors:  Kutty Selva Nandakumar; Lars Svensson; Rikard Holmdahl
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

10.  Effector memory CD4+T cells in mesenteric lymph nodes mediate bone loss in food-allergic enteropathy model mice, creating IL-4 dominance.

Authors:  Aiko Ono-Ohmachi; Satoki Yamada; Satoru Uno; Masato Tamai; Kohei Soga; Shotaro Nakamura; Nobuyuki Udagawa; Yuko Nakamichi; Masanori Koide; Yoshikazu Morita; Tomohiro Takano; Takumi Itoh; Shigeru Kakuta; Chikao Morimoto; Shuji Matsuoka; Yoichiro Iwakura; Michio Tomura; Hiroshi Kiyono; Satoshi Hachimura; Haruyo Nakajima-Adachi
Journal:  Mucosal Immunol       Date:  2021-07-29       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.